• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三例起源于多能髓系祖细胞的近四倍体急性髓系白血病。

Three cases of near-tetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors.

作者信息

Lemez P, Michalová K, Zemanová Z, Marinov I, Trpáková A, Moravcová J, Jelínek J

机构信息

Institute of Hematology and Blood Transfusion, Prague, Czech Republic.

出版信息

Leuk Res. 1998 Jul;22(7):581-8. doi: 10.1016/s0145-2126(97)00177-x.

DOI:10.1016/s0145-2126(97)00177-x
PMID:9680107
Abstract

We report three cases of acute myeloid leukemia (AML) with a near-tetraploid karyotype in most metaphases while lacking chromosomal abnormalities typical for AML. All patients, 63, 72 and 81 years old, were female. In two cases, AML was diagnosed 5-7 months after a cytopenic period while the third patient had a secondary AML after therapy for a pleural tumor. Leukemic blasts were classified as AML M0, AML M1 and AML without further specification. Two patients died on the 18th and 52nd day after the start of cytotoxic chemotherapy, the third patient refused chemotherapy and died 22 days after the diagnosis. The three patients may represent a distinct AML category with the following features: (1) the near-tetraploid karyotype in most bone marrow metaphases examined at diagnosis of AML; (2) the presence of very large myeloid blasts in the bone marrow and dysplastic changes in erythroid and/or megakaryocytic lineages pointing to the origin of AML in pluripotent myeloid progenitor cells; (3) the expression of the CD34 antigen; (4) the low growth of granulocyte-macrophage colony forming cells in culture; and (5) the presence of a preleukemic phase, a higher age and a poor prognosis.

摘要

我们报告了三例急性髓系白血病(AML)患者,其多数中期细胞具有近四倍体核型,同时缺乏AML典型的染色体异常。所有患者均为女性,年龄分别为63岁、72岁和81岁。其中两例患者在血细胞减少期5 - 7个月后被诊断为AML,第三例患者在胸膜肿瘤治疗后发生继发性AML。白血病原始细胞分别被分类为AML M0、AML M1以及未进一步明确分类的AML。两名患者在细胞毒性化疗开始后的第18天和第52天死亡,第三名患者拒绝化疗,在诊断后22天死亡。这三名患者可能代表一种具有以下特征的独特AML类型:(1)在AML诊断时检查的多数骨髓中期细胞具有近四倍体核型;(2)骨髓中存在非常大的髓系原始细胞,以及红系和/或巨核细胞系的发育异常改变,提示AML起源于多能髓系祖细胞;(3)CD34抗原表达;(4)培养中粒细胞 - 巨噬细胞集落形成细胞生长低下;(5)存在白血病前期、较高年龄以及预后不良。

相似文献

1
Three cases of near-tetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors.三例起源于多能髓系祖细胞的近四倍体急性髓系白血病。
Leuk Res. 1998 Jul;22(7):581-8. doi: 10.1016/s0145-2126(97)00177-x.
2
[A female patient with near-tetraploid acute myeloid M4 leukemia].[一名患有近四倍体急性髓系M4白血病的女性患者]
Cas Lek Cesk. 1994 Nov 21;133(22):702-5.
3
Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.低细胞性急性白血病的诊断标准:一种与明显急性白血病和骨髓增生异常综合征不同的临床实体。
Leuk Res. 1996 Jul;20(7):563-74. doi: 10.1016/0145-2126(95)00136-0.
4
Acute erythroid neoplastic proliferations. A biological study based on 62 patients.急性红系肿瘤增殖。一项基于62例患者的生物学研究。
Haematologica. 2002 Feb;87(2):148-53.
5
Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.与急性髓系白血病(AML)患者诊断时原始细胞免疫表型特征相关的髓系酶谱。
Neoplasma. 2005;52(3):211-8.
6
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations.通过对CD34+亚群进行细胞遗传学分析,在急性髓系白血病早期造血干细胞水平上存在恶性转化的证据。
Blood. 1995 Oct 15;86(8):2906-12.
7
Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.急性髓系白血病中CD34表达与染色体异常的相关性,但与临床结局无关。
Am J Hematol. 1996 Nov;53(3):175-80. doi: 10.1002/(SICI)1096-8652(199611)53:3<175::AID-AJH5>3.0.CO;2-W.
8
Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.人重组干扰素诱导蛋白-10抑制正常和急性髓性白血病祖细胞的增殖。
Leukemia. 1996 May;10(5):757-65.
9
Near-tetraploid poorly differentiated acute myeloid leukemia M0 diagnosed by short-term cultures with a phorbol ester TPA.通过用佛波酯TPA进行短期培养诊断出的近四倍体低分化急性髓系白血病M0
Leuk Res. 1994 Jul;18(7):493-7. doi: 10.1016/0145-2126(94)90087-6.
10
Definition of acute biphenotypic leukemia.急性双表型白血病的定义。
Haematologica. 1997 Jan-Feb;82(1):64-6.

引用本文的文献

1
Identification of chromosomal abnormalities and genomic features in near-triploidy/tetraploidy-acute leukemia by fluorescence in situ hybridization.通过荧光原位杂交技术鉴定近三倍体/四倍体急性白血病中的染色体异常和基因组特征。
Cancer Manag Res. 2019 Feb 15;11:1559-1567. doi: 10.2147/CMAR.S189025. eCollection 2019.
2
Clinicopathological analysis of near-tetraploidy/tetraploidy acute myeloid leukaemia.近四倍体/四倍体急性髓系白血病的临床病理分析
J Clin Pathol. 2015 Mar;68(3):236-40. doi: 10.1136/jclinpath-2014-202697. Epub 2015 Jan 6.
3
Two cases of near-tetraploidy in acute leukemias of ambiguous lineage.
两例谱系不明的急性白血病中的近四倍体病例。
Ann Lab Med. 2013 Sep;33(5):371-4. doi: 10.3343/alm.2013.33.5.371. Epub 2013 Aug 8.
4
A tetraploid minimally differentiated acute myeloblastic leukemia with extensive erythrophagocytosis: a case report and literature review.四体性低分化急性髓细胞白血病伴广泛红细胞吞噬现象:病例报告及文献复习。
Int J Hematol. 2012 Dec;96(6):801-5. doi: 10.1007/s12185-012-1179-6. Epub 2012 Sep 28.
5
Deficiency in myosin light-chain phosphorylation causes cytokinesis failure and multipolarity in cancer cells.肌球蛋白轻链磷酸化不足导致癌细胞的胞质分裂失败和多极分裂。
Oncogene. 2010 Jul 22;29(29):4183-93. doi: 10.1038/onc.2010.165. Epub 2010 May 24.
6
Rare coincidence of hypertriploid chromosome number and aberrant coexpression of the lymphoid-associated antigen CD5 in acute myeloid Leukaemia FAB M0.急性髓系白血病FAB M0中三倍体染色体数罕见巧合与淋巴样相关抗原CD5异常共表达
Leukemia. 2003 Jun;17(6):1188-9. doi: 10.1038/sj.leu.2402965.
7
CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis.通过荧光原位杂交分析检测到的伴有双t(8;21)(q22;q22)易位和Aml1/ETO重排的CD7+近四倍体急性髓细胞白血病M2
Int J Hematol. 2001 Oct;74(3):316-21. doi: 10.1007/BF02982067.